Baxter International Inc. (BAX) is a global, multi-billion dollar healthcare company that specializes in delivering critical therapies for people with life-threatening conditions. This Fortune 500 company is based in Deerfield, Illinois, and has a reach in over 100 countries. The company was founded in 1931 by Dr. Donald Baxter, a Los Angeles-based physician, who believed that intravenous therapy could be used effectively outside of the hospital setting.
Baxter International Inc. thrives on a mission to save and sustain lives. Across its portfolio of products and services, Baxter is highly committed to addressing numerous issues faced by patients and healthcare professionals alike. Its expansive product line encompasses renal care, nutritional therapies, pharmaceuticals, surgical products, and several other therapeutic categories. Baxter's most innovative product line is its renal care products, which include dialysis equipment and related disposables.
The company operates through two primary divisions: Hospital Products and Renal. The Hospital Products division comprises fluid systems, injectable pharmaceuticals, inhaled anesthetics, contract manufacturing, and infusion systems. Besides, the division also offers products used in the treatment of acute and chronic medical conditions, such as hemophilia and other bleeding disorders, cancer, kidney disease, and infectious diseases.
The renal division, on the other hand, centers on products and services designed to treat end-stage renal disease (ESRD) and kidney failure. It demonstrates Baxter's commitment to enhancing the quality of patients' lives through innovative technologies that enable at-home peritoneal dialysis treatment.
With a robust track record of growth and innovation, BAX continually expands its product portfolio through strategic acquisitions. Additionally, apart from manufacturing vital health products, Baxter also offers essential services such as training, technical support, and customized patient care. The company's commitment to CSR (Corporate Social Responsibility) is also clearly reflected in its efforts towards improving access to care, fostering tomorrow’s innovation, driving economic development, and strengthening communities around the globe.
One of the company's key strengths is their R&D department, which is dedicated to developing breakthrough technologies in medical treatments, contributing to the company’s leading position in the global healthcare market. With roughly 50,000 employees worldwide, Baxter International Inc. continues to uphold their commitment to operating with the highest standards of integrity, while pursuing initiatives that lead to a sustainable future in healthcare.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Baxter International (BAX) is undergoing a portfolio transformation, focusing on operational efficiency and growth in connected-care and advanced surgery businesses. While facing headwinds from manufacturing costs, tariffs, and regulatory issues with Novum IQ, the company benefits from large addressable markets and strategic simplification. Analysts project revenue growth for 2026 but a decrease in adjusted EPS, despite recent positive revisions.
Otsuka ICU Medical LLC has issued a recall for one lot of 0.9% Sodium Chloride Injection, USP (saline) after a customer discovered a bag of concentrated potassium chloride inside a saline-labeled overwrap. The recall, affecting lot 1042188, targets hospitals and clinics, though no adverse events have been reported. The primary safeguard against accidental administration is the clear labeling on the inner potassium chloride bag, requiring healthcare professionals to check before use.
This article highlights 11 useful tools available at Tractor Supply Co. for under $50, emphasizing that good quality tools can be found at affordable prices. It details various tools from brands like DeWalt, Crescent, Skil, GearWrench, Fiskars, Arrow, Black+Decker, and Apollo Tools, explaining their features and practical applications for homeowners and DIY enthusiasts. The selections aim to provide versatility and value, proving that expanding a toolkit doesn't require a large investment.
The US FDA has issued a warning to Bausch + Lomb, indicating a potential recall and production interruption for the company. This warning suggests that a recall would be necessary if the firm's response to the FDA's concerns is not deemed satisfactory. The article highlights the implications for Bausch + Lomb's ophthalmic supply chain and manufacturing operations.
Baxter International Inc. (BAX) currently trades at $23.80, with analysts projecting a 20.7% upside potential, targeting $28.73. Despite negative EPS and ROE, the company shows a 5.3% revenue growth and over $1 billion in free cash flow, suggesting financial resilience. Analyst sentiment is cautiously optimistic with a majority hold rating, highlighting both growth opportunities and profitability challenges.
Baxter International's stock is experiencing a turnaround in 2026, driven by new management's successful plans after years of underperformance. Despite potential volatility, Morningstar believes the stock is 38% undervalued with a fair value estimate of $40, rating it as a compelling turnaround play. The company, a top-tier medical supplier, is expected to see profit growth due to easing supply chain pressures and new contracts, with an 8% annual EPS growth forecast through 2030.